Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 2, 2026	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Market Capitalization	29	9	5	8	9	3
Market Cap Growth	1.78%	70.79%	-33.85%	-12.43%	221.01%	-41.95%
Enterprise Value	28	9	5	8	8	3
Last Close Price	0.16	0.07	0.04	0.07	0.09	0.04
PB Ratio	19.80	20.15	3.70	5.48	4.81	9.32
P/TBV Ratio	19.80	20.15	3.70	5.48	4.81	9.32
Debt / Equity Ratio	0.03	0.13	0.03	0.02	0.02	0.88
Net Debt / Equity Ratio	-0.63	-0.25	0.02	-0.01	-0.41	0.87
Net Debt / EBITDA Ratio	0.36	0.07	-0.03	0.01	0.40	-0.27
Net Debt / FCF Ratio	0.34	0.24	-0.03	0.01	0.37	-0.61
Quick Ratio	0.49	0.11	0.06	0.10	1.39	0.02
Current Ratio	0.58	0.17	0.13	0.27	1.43	0.03
Return on Equity (ROE)	-261.78%	-181.07%	-96.50%	-104.07%	-185.44%	-214.90%
Return on Assets (ROA)	-52.14%	-39.76%	-35.90%	-43.03%	-64.23%	-49.37%
Return on Capital Employed (ROCE)	-167.60%	-300.60%	-82.10%	-106.70%	-101.50%	-311.90%
Earnings Yield	-10.94%	-18.83%	-26.36%	-21.86%	-22.39%	-39.91%
FCF Yield	-9.47%	-5.17%	-21.97%	-24.94%	-22.77%	-15.21%
Buyback Yield / Dilution	-14.68%	-5.46%	-21.03%	-13.89%	-34.24%	-22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.